Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$18.74 Million

AU$30.26 Million AUD

Market Cap Rank

#27176 Global

#660 in Australia

Share Price

AU$0.09

Change (1 day)

+3.41%

52-Week Range

AU$0.03 - AU$0.25

All Time High

AU$0.52

Neuroscientific Biopharmaceuticals Ltd - Asset Resilience Ratio

Latest as of June 2025: 42.83%

Neuroscientific Biopharmaceuticals Ltd (NSB) has an Asset Resilience Ratio of 42.83% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$7.27 Million

Cash + Short-term Investments

Total Assets

AU$16.96 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Neuroscientific Biopharmaceuticals Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$7.27 Million	42.83%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$7.27 Million	42.83%

Asset Resilience Insights

Very High Liquidity: Neuroscientific Biopharmaceuticals Ltd maintains exceptional liquid asset reserves at 42.83% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.